http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/?utm_source=rss&utm_medium=rss&utm_campaign=us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/#comments Sun, 09 Nov 2025 08:01:06 +0000 Tapan Ray http://www.tapanray.in/?p=10996 Continue reading →]]> http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/feed/ 0 http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/?utm_source=rss&utm_medium=rss&utm_campaign=when-patents-meet-patients-why-india-revoked-novartis-vymada-patent http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/#comments Thu, 18 Sep 2025 12:11:29 +0000 Tapan Ray http://www.tapanray.in/?p=10971 Continue reading →]]> http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/feed/ 0 http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/?utm_source=rss&utm_medium=rss&utm_campaign=robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/#comments Fri, 30 May 2025 00:00:36 +0000 Tapan Ray http://www.tapanray.in/?p=10902 Continue reading →]]> http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/feed/ 0 http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/?utm_source=rss&utm_medium=rss&utm_campaign=exploiting-indias-weakness-for-monopolistic-commercial-gain http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/#comments Mon, 08 May 2023 00:00:11 +0000 Tapan Ray http://www.tapanray.in/?p=10776 Continue reading →]]> http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/feed/ 0 http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/#comments Mon, 28 Mar 2022 00:00:33 +0000 Tapan Ray http://www.tapanray.in/?p=10678 Continue reading →]]> http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/feed/ 0 http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/#comments Mon, 29 Nov 2021 00:00:53 +0000 Tapan Ray http://www.tapanray.in/?p=10615 Continue reading →]]> http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/feed/ 0 http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/?utm_source=rss&utm_medium=rss&utm_campaign=focus-more-to-create-patient-perceived-value-of-brand-outcomes http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/#comments Mon, 01 Nov 2021 00:00:27 +0000 Tapan Ray http://www.tapanray.in/?p=10603 Continue reading →]]> http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/feed/ 0 http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/?utm_source=rss&utm_medium=rss&utm_campaign=a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/#comments Mon, 11 Oct 2021 00:00:26 +0000 Tapan Ray http://www.tapanray.in/?p=10595 Continue reading →]]> http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/feed/ 0 http://www.tapanray.in/a-rare-strategic-acrobatic-feat-in-covid-time/?utm_source=rss&utm_medium=rss&utm_campaign=a-rare-strategic-acrobatic-feat-in-covid-time http://www.tapanray.in/a-rare-strategic-acrobatic-feat-in-covid-time/#comments Mon, 21 Dec 2020 00:00:09 +0000 Tapan Ray http://www.tapanray.in/?p=10376 Continue reading →]]> http://www.tapanray.in/a-rare-strategic-acrobatic-feat-in-covid-time/feed/ 0 http://www.tapanray.in/covid-propels-healthcare-into-a-virtual-world-a-new-growth-driver-for-pharma/?utm_source=rss&utm_medium=rss&utm_campaign=covid-propels-healthcare-into-a-virtual-world-a-new-growth-driver-for-pharma http://www.tapanray.in/covid-propels-healthcare-into-a-virtual-world-a-new-growth-driver-for-pharma/#comments Mon, 19 Oct 2020 00:00:43 +0000 Tapan Ray http://www.tapanray.in/?p=10299 Continue reading →]]> http://www.tapanray.in/covid-propels-healthcare-into-a-virtual-world-a-new-growth-driver-for-pharma/feed/ 0